Back to News
Market Impact: 0.35

I Agree, 'Saaspocalypse Is Nonsense'- 3 Stocks I'm Buying

Source: seekingalpha.com

Corporate EarningsTechnology & InnovationAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
I Agree, 'Saaspocalypse Is Nonsense'- 3 Stocks I'm Buying

CrowdStrike (CRWD) earnings and record Net New ARR helped IGV push above June highs, signaling software outperformance vs. SMH and the S&P 500 since May. CRWD defended its premium valuation by accelerating revenue and raising full-year growth forecasts, reinforcing a bullish setup despite elevated multiples. Salesforce (CRM) results further improve the ServiceNow (NOW) thesis, with AI-driven ACV now surpassing $1B and strong large-customer growth making dip-buying near the 20WMA more attractive.

Analysis

The important signal is not the earnings beats themselves; it is that the market is now paying up for proof of AI monetization in software instead of just AI usage. That tends to favor the few names that can translate product adoption into durable billings and net retention, while squeezing out lower-quality growth software that still relies on narrative rather than rev acceleration. In the near term, this can keep IGV leadership intact versus SMH and the S&P as systematic and momentum capital chases the breakout.

CrowdStrike is the cleanest beneficiary because security budgets are the last place CIOs are willing to cut, so a reacceleration in ARR has disproportionate multiple support. ServiceNow is the second-order winner: if large-customer AI ACV is really inflecting, the market may start underwriting a broader enterprise workflow monetization cycle, which would pressure adjacent enterprise platforms to show their own AI payback faster. The spillover risk is that this becomes a narrow winner-take-most tape, where only the highest-conviction compounders keep premium valuations while the rest of software gets re-rated lower.

The main risk is that this is a duration trade masquerading as fundamentals. If real rates back up, or if the next few software prints fail to confirm that AI ACV is broadening beyond a handful of marquee customers, the multiple expansion can reverse quickly over 1-3 months. A clean falsifier is a failed retest of the June breakout in IGV or any guide-down in forward growth that breaks the current revision momentum; over 6-18 months, the thesis weakens if enterprise AI spend stays concentrated in infrastructure rather than applications.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.55

Ticker Sentiment

CRM0.60
CRWD0.85
NOW0.35

Key Decisions for Investors

  • Long CRWD on any 2-4% post-earnings consolidation; best earnings quality in the group and the cleanest support for premium multiple retention over the next 1-3 months. Risk/reward: favorable if ARR reacceleration continues; exit if the next print shows deceleration in net new ARR or billings.
  • Initiate a tactical long NOW on pullbacks to the 20WMA; use it as the higher-beta beneficiary of the AI workflow monetization theme. Hold 1-3 months; invalidate on a weekly close below the 20WMA or if large-customer ACV growth fails to broaden.
  • Pair trade: long IGV / short SMH for a 4-8 week relative-value rotation if software leadership persists and semis stall. This isolates the factor shift from pure market beta; cover if SMH reclaims relative strength or if rates fall sharply and reflate AI infrastructure names.
  • Relative value: long NOW / short CRM only on a meaningful spread widening after the next sector move, not immediately after earnings. The thesis is that NOW still has more runway to re-rate on AI monetization than CRM; stop if CRM’s growth re-accelerates or if NOW’s large-account expansion cools.

More News

From AllMind Research

Browse all research